When did Apogee Therapeutics, Inc. report Q4 2024 earnings?

Apogee Therapeutics, Inc. (APGE) reported Q4 2024 earnings on March 3, 2025 before market open.

What were Apogee Therapeutics, Inc.'s Q4 2024 revenue and EPS?

Apogee Therapeutics, Inc. reported eps of $-1.19 for Q4 2024.

Did Apogee Therapeutics, Inc. beat estimates in Q4 2024?

EPS missed the consensus estimate of $-0.94 by $0.25.

Where can I find Apogee Therapeutics, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-030385) directly on SEC EDGAR. The filing index links above go to sec.gov.

Apogee Therapeutics, Inc. APGE Q4 2024 Annual earnings

Reported March 3, 2025 · Before market open

EPS-$1.19Miss by $0.25

EPS estimate-$0.94

Next report

Aug 10, 2026 (In 1 week)

Revenue estimate$10.0M

EPS estimate-$1.10

Financials

Q4 2024

Income statement

See full

Operating income-$75.9M-104%

Net income-$67.2M-112%

EPS (diluted)-$1.19-272%

Balance sheet

See full

Cash & equivalents$141.8M+19.8%

Total debt$11.8M+492%

Total assets$754.0M+87.8%

Cash flow

See full

Operating cash flow-$67.7M-128%

CapEx--100%

Free cash flow-$67.7M-261%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$2.58B+92.1%

Enterprise value$2.45B+99.8%

Returns & leverage

See full

Current ratio18.5×-0.8×

Versus estimates

Diluted EPS

Q1 2026-$1.06Beat by $0.06 Q4 2025-$1.03Beat by $0.02 Q3 2025-$1.11Beat by $0.01 Q2 2025-$1.13Miss by $0.10 Q1 2025-$0.95Beat by $0.24

Q4 2024-$1.19Miss by $0.25

Ask the moment Apogee Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Apogee Therapeutics, Inc. report Q4 2024 earnings?: Apogee Therapeutics, Inc. (APGE) reported Q4 2024 earnings on March 3, 2025 before market open.
What were Apogee Therapeutics, Inc.'s Q4 2024 revenue and EPS?: Apogee Therapeutics, Inc. reported eps of $-1.19 for Q4 2024.
Did Apogee Therapeutics, Inc. beat estimates in Q4 2024?: EPS missed the consensus estimate of $-0.94 by $0.25.
Where can I find Apogee Therapeutics, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-030385) directly on SEC EDGAR. The filing index links above go to sec.gov.